What Happens When You Stop a GLP-1: The Regain Problem and How to Avoid It

The STEP-4 trial randomized users who'd lost weight on semaglutide to either continue or switch to placebo. The placebo group regained two-thirds of their lost weight within 12 months. The continuation group kept losing slightly.

The takeaway: GLP-1s treat the disease of obesity the way statins treat hypercholesterolemia. Stopping them is not 'graduating' — it's stopping treatment for a chronic condition.

Without the medication, appetite signaling returns to its pre-treatment level. Combine that with the lower BMR that follows any significant weight loss, and the calorie gap that was easy to maintain on the drug becomes very hard to maintain off it.

If you must stop (cost, side effects, family planning), don't go cold turkey from the top dose.

• Step down one dose level every 4–6 weeks instead of stopping at the maintenance dose
• During each step, lock in your protein and resistance training
• Track weight weekly and waist monthly — at the first sign of a 5-lb regain, talk to your clinician about going back up a dose

Some patients do successfully maintain weight after stopping. The pattern: they used the medication window (12–24 months) to build durable habits — protein-forward eating, 8,000+ daily steps, twice-weekly lifting, and consistent sleep. Without those habits in place before tapering, regain is the rule, not the exception.